🚀 Excited to share our first preprint on single-cell transcriptional landscapes of Aedes aegypti with Sarah Merkling , exploring dynamic changes in mosquito midgut and abdominal fat body after a bloodmeal. 🦟biorxiv.org/content/10.110…

New research in Science Immunology identifies the pore-forming protein APOL7C as a driver of phagosomal rupture and antigen cross-presentation in activated dendritic cells. bit.ly/4eeoG0W

@timotheebruel.bsky.social ;-)

Two papers. On the left, a non-randomized, non-crossover study showing that a one-off sauna exposure significantly decreased arterial stiffness, with implications on cardiovascular health. On the right, a randomized, crossover (more robust) study, showing no benefits on

HIV-1 budding requires cortical actin disassembly by the oxidoreductase MICAL1 Congrats to Echard Lab, Pasteur Institute, Paris revealing an unexpected connection between oxidoreduction and viral budding. PNAS pnas.org/doi/10.1073/pn…

#SARSCoV2 entry and fusion are independent of ACE2 localization to lipid ##rafts. Congrats to Will Bolland Julian Buchrieser and colleagues Journal of #virology journals.asm.org/eprint/WHJP5QN…

A new Science Advances study of more than 482,000 Wikipedia readers identifies the knowledge networks associated with the three main styles of curiosity. Learn more: bit.ly/3YHzaQA

The combination of nivolumab and ipilimumab in patients with metastatic colorectal cancer led to 24-month progression-free survival of 72%, as compared with 14% with chemotherapy. Read the full CheckMate 8HW trial results: nej.md/4eGp1tj

🎉 Bravo à @michaelwhite_36, chercheur à l’Institut Pasteur, lauréat de l'ERC Consolidator Grants ! Son projet ULTIMASero explore les maladies infectieuses via des tests multiplex, études épidémiologiques et modélisation statistique.

"AI will not replace people anytime soon, but people who use AI might replace those who don’t." nature.com/articles/d4158…

Get ready! Negative Strand RNA Virus meeting #NSV2025 registration will open soon! Co-organized with wendybarclay, Sean P.J. Whelan and Paul Duprex. It will be in vibrant Montpellier, south of France, in June 2025! Please RT

Our latest discovery of how intrinsic immunity regulates SNARE activity to promote lysosomal delivery of cellular and viral cargo is now published in The EMBO Journal: embopress.org/doi/full/10.10… National Cancer Institute NIH

1/ We are excited to share our new paper from Fahd Al Qureshah, PhD | فهد آل قريشه published today in Journal of Experimental Medicine about humans with autosomal dominant IFNAR1 deficiency (doi.org/10.1084/jem.20…).

A must read ! We need a better model to predict antibody effector functions. journals.asm.org/doi/full/10.11…

Antiviral activity of #Tecovirimat against #Mpox virus clades 1a, 1b, 2a and 2b in cell culture. Collaborative work with Pablo GUARDADO-CALVO Etienne Simon-Loriere and JC Manuguera Institut Pasteur, since 1887 biorxiv.org/content/10.110…

🎉 Aujourd'hui, nous célébrons l'anniversaire de la naissance de Louis Pasteur. Son héritage scientifique continue d'inspirer nos recherches pour relever les défis de santé publique d'aujourd'hui et de demain. #LouisPasteur

🎉 La Société Française de Virologie vous souhaite une excellente année 2025 !  ✨ Que cette nouvelle année soit riche en succès pour toute la communauté scientifique. 🦠 Rendez-vous aux #JFV2025 pour écrire ensemble une nouvelle page en virologie ! 🔬 #BonneAnnée2025

🚨 New preprint alert 🚨 We searched for the presence of coronaviruses in >200 bat individuals across Spain 🦠🦇🇪🇸. We recovered 6 complete coronavirus genomes, including 3 novel species. One of them could use bat and human ACE2 for entry. biorxiv.org/content/10.110…

🚨 Preprint alter - bis 🚨 I am thrilled to share our last preprint where we identify and characterize a new coronavirus receptor! 🦠 This work was done in collaboration with the team of Félix Rey @virusfusion007 at the Institut Pasteur. A 🧶 below... biorxiv.org/content/10.110…

Check out our new paper on molecular characterization of RSV infections in elderly patients during the 2023/2024 season in the era of nirsevimab introduction, just published in JID pubmed.ncbi.nlm.nih.gov/39895281/